Biophotonics Market Overview
The global biophotonics market is expected to grow at 11.30 % CAGR from 2020 to 2029. It is expected to reach above USD 141.14 Billion by 2029 from USD 53.85 Billion in 2020.
Biophotonics is a multidisciplinary field that involves the use of light-based technologies to study, diagnose, and treat biological systems. It encompasses the interaction of light with biological tissues, cells, molecules, and other biomaterials to gain insights into their structure, function, and behavior. Biophotonics combines principles of optics, biology, physics, and engineering to develop and apply innovative techniques and tools for a wide range of applications in medicine, life sciences, and environmental sciences. Biophotonics technologies utilize various optical techniques such as imaging, spectroscopy, microscopy, sensing, and therapy to enable non-invasive, label-free, and minimally invasive approaches for studying biological systems at different scales, from macroscopic to microscopic and nanoscopic levels.
ATTRIBUTE |
DETAILS |
Study period |
2020-2029 |
Base year |
2021 |
Estimated year |
2022 |
Forecasted year |
2022-2029 |
Historical period |
2018-2020 |
Unit |
Value (USD Billion) |
Segmentation |
By End User, Application and region. |
By End User |
|
By Application |
- See-through Imaging
- Inside Imaging
- Spectro Molecular
- Surface Imaging
- Microscopy
- Light Therapy
- Analytical Sensing
- Biosensors
|
By Region |
- North America
- Asia Pacific
- Europe
- South America
- Middle East Asia & Africa
|
The growing need for early disease detection and personalized medicine is a significant driver for the biophotonics market. Early detection of diseases, such as cancer, cardiovascular diseases, and neurological disorders, can lead to more effective treatment outcomes and improved patient outcomes. Biophotonics technologies offer non-invasive, sensitive, and real-time methods for early disease detection, which can enable timely interventions and personalized treatment plans tailored to an individual's unique characteristics.
High costs associated with biophotonics technologies, including research and development, manufacturing, instrumentation, infrastructure, regulatory compliance, training, and market competition, can be a significant restraint on their adoption. These costs pose challenges for smaller companies or research institutions, limit accessibility in certain settings, and impact affordability and availability of biophotonics-based products and services. Addressing the cost challenges through increased funding, optimized manufacturing processes, regulatory efficiencies, and skill development programs may help in mitigating this restraint and promoting wider adoption of biophotonics technologies.
The increasing healthcare expenditure globally presents an opportunity for the adoption of biophotonics technologies. As healthcare expenditure continues to rise due to factors such as aging populations, increasing chronic diseases, and growing healthcare infrastructure, there is a growing need for cost-effective, efficient, and non-invasive healthcare solutions. Biophotonics technologies, with their capabilities in imaging, sensing, diagnostics, therapy, and monitoring, can offer innovative and advanced solutions for various healthcare applications. Biophotonics can enable early disease detection, personalized medicine, and precision therapies, which can contribute to improved patient outcomes and cost savings in healthcare. Therefore, the increasing healthcare expenditure provides opportunities for the wider adoption of biophotonics technologies in healthcare settings globally.
The COVID-19 pandemic had a positive impact on the biophotonics market, including increased demand for diagnostics such as fluorescence-based diagnostics, spectroscopy, and imaging for COVID-19 testing. The adoption of tele healthcare and remote monitoring had accelerated, creating opportunities for biophotonics technologies in virtual consultations and home-based monitoring. Increased research collaborations and funding had facilitated the development of new biophotonics-based solutions for COVID-19 detection and therapy. The pandemic had also highlighted the importance of healthcare preparedness, showcasing the potential of biophotonics in addressing healthcare challenges. Furthermore, advancements in biophotonics technologies developed for COVID-19 have the potential for broader applications beyond the pandemic, such as cancer detection, neuroimaging, ophthalmology, and cardiovascular disease management. These factors had contributed to the positive impact of COVID-19 on the biophotonics market, driving its growth and expansion in various healthcare fields.
[caption id="attachment_20615" align="aligncenter" width="1000"]
Biophotonics Market | Exactitude Consultancy[/caption]
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL BIOPHOTONICS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON BIOPHOTONICS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL BIOPHOTONICS MARKET BY END USER, 2020-2029, (USD BILLION).
- MEDICAL DIAGNOSTICS
- MEDICAL THERAPEUTIC
- TESTS & COMPONENTS
- NONMEDICAL APPLICATION
- GLOBAL BIOPHOTONICS MARKET BY APPLICATION, 2020-2029, (USD BILLION).
- SEE-THROUGH IMAGING
- INSIDE IMAGING
- SPECTRO MOLECULAR
- SURFACE IMAGING
- MICROSCOPY
- LIGHT THERAPY
- ANALYTICAL SENSING
- BIOSENSORS
- GLOBAL BIOPHOTONICS MARKET BY REGION, 2020-2029, (USD BILLION).
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- COMPANY PROFILES*(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- THERMO FISHER SCIENTIFIC INC.
- OXFORD TECHNOLOGIES
- CARL ZEISS AG
- GLENBROOK TECHNOLOGIES INC.
- BECTON, DICKINSON AND COMPANY
- HAMAMATSU PHOTONICS K.K.
- LUMENIS LTD.
- OLYMPUS CORPORATION
- PERKINELMER INC.
- ZENALUX BIOMEDICAL INC.
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL BIOPHOTONICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 2 GLOBAL BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 3 GLOBAL BIOPHOTONICS MARKET BY REGION (USD BILLIONS), 2020-2029
TABLE 4 NORTH AMERICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 5 NORTH AMERICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 6 NORTH AMERICA BIOPHOTONICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 7 US BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 8 US BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 9 CANADA BIOPHOTONICS MARKET BY END USER (BILLIONS), 2020-2029
TABLE 10 CANADA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 11 MEXICO BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 12 MEXICO BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 13 SOUTH AMERICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 14 SOUTH AMERICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 15 SOUTH AMERICA BIOPHOTONICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 16 BRAZIL BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 17 BRAZIL BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 18 ARGENTINA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 19 ARGENTINA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 20 REST OF SOUTH AMERICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 21 REST OF SOUTH AMERICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 22 ASIA -PACIFIC BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 23 ASIA -PACIFIC BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 24 ASIA -PACIFIC BIOPHOTONICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 25 INDIA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 26 INDIA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 27 CHINA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 28 CHINA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 29 JAPAN BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 30 JAPAN BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 31 SOUTH KOREA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 32 SOUTH KOREA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 33 AUSTRALIA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 34 AUSTRALIA HYBRID FUNCTIONBY APPLICATION (USD BILLION), 2020-2029
TABLE 35 AUSTRALIA BIOPHOTONICS MARKET BY FUNCTION (USD BILLIONS), 2020-2029
TABLE 36 AUSTRALIA BIOPHOTONICS MARKET BY ORGANIZATION SIZE (USD BILLION), 2020-2029
TABLE 37 REST OF ASIA PACIFIC BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 38 REST OF ASIA PACIFIC HYBRID FUNCTIONBY APPLICATION (USD BILLION), 2020-2029
TABLE 39 EUROPE BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 40 EUROPE BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 41 EUROPE BIOPHOTONICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 42 GERMANY BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 43 GERMANY BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 44 UK BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 45 UK BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 46 FRANCE BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 47 FRANCE BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 48 ITALY BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 49 ITALY BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 50 SPAIN BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 51 SPAIN BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 52 REST OF EUROPE BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 53 REST OF EUROPE BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 54 MIDDLE EAST AND AFRICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 55 MIDDLE EAST AND AFRICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 56 MIDDLE EAST ABD AFRICA BIOPHOTONICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 57 UAE BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 58 UAE BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 59 SOUTH AFRICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 60 SOUTH AFRICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 61 REST OF MIDDLE EAST AND AFRICA BIOPHOTONICS MARKET BY END USER (USD BILLIONS), 2020-2029
TABLE 62 REST OF MIDDLE EAST AND AFRICA BIOPHOTONICS MARKET BY APPLICATION (USD BILLION), 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL BIOPHOTONICS MARKET BY END USER, USD BILLION, 2020-2029
FIGURE 9 GLOBAL BIOPHOTONICS MARKET BY APPLICATION, USD BILLION, 2020-2029
FIGURE 10 GLOBAL BIOPHOTONICS MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 11 PORTER’S FIVE FORCES MODEL
FIGURE 12 GLOBAL BIOPHOTONICS MARKET BY END USER, USD BILLION, 2021
FIGURE 13 GLOBAL BIOPHOTONICS MARKET BY APPLICATION, USD BILLION, 2021
FIGURE 14 GLOBAL BIOPHOTONICS MARKET BY REGION, USD BILLION, 2021
FIGURE 15 MARKET SHARE ANALYSIS
FIGURE 16 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 17 OXFORD TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 18 CARL ZEISS AG: COMPANY SNAPSHOT
FIGURE 19 GLENBROOK TECHNOLOGIES INC.: COMPANY SNAPSHOT
FIGURE 20 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 21 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT
FIGURE 22 LUMENIS LTD.: COMPANY SNAPSHOT
FIGURE 23 OLYMPUS CORPORATION: COMPANY SNAPSHOT
FIGURE 24 PERKINELMER INC.: COMPANY SNAPSHOT
FIGURE 25 ZENALUX BIOMEDICAL INC.: COMPANY SNAPSHOT